Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Astrazeneca image

AstraZeneca and Harvard team up for diabetes research

March 25, 2015 Research and Development, Sales and Marketing AZ, AstraZeneca, Havard, cardiovascular, diabetes, metabolic

AstraZeneca is to work with Harvard University’s department of stem cell and regenerative biology to develop new treatments in diabetes. …
News
timothy_wright_teva

Teva hires new business development head

March 25, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, timothy wright

Teva Pharmaceutical Industries has confirmed the appointment of Timothy Wright to its executive leadership team to head up business development, …
Appointment
Takeda image

Takeda buys license to ImmunoGen cancer tech

March 24, 2015 Research and Development, Sales and Marketing ADC, Immunogen, Takeda, antibody, conjugate, merger

Takeda has licensed the exclusive rights to use ImmunoGen’s popular antibody-drug conjugate (ADC) technology to develop new cancer drugs. The …
News
FDA image

FDA lifts ban on Pfizer Lilly pain study

March 24, 2015 Research and Development, Sales and Marketing Cancer, FDA, Pfizer, lilly, pain, tanezumab

Pfizer and Eli Lilly will resume Phase III clinical trials of tanezumab following the FDA lifting a ban on trials …
News
Stefan Oschmann

Chief executive promotion at Merck KGaA

March 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Karl-Ludwig Kley, Merck, Merck KGaA, Merck Serono, Stefan Oschmann, chief executive

Merck KGaA is to promote its deputy chief executive Stefan Oschmann to replace Karl-Ludwig Kley in the top job next …
News
christa_wirthumer-hoche

EMA elects new vice-chair

March 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Christa Wirthumer-Hoche, EMA

The European Medicines Agency has elected Dr Christa Wirthumer-Hoche, the head of the Austrian Medicines and Medical Devices Agency, as …
Appointment
steve_cottrell3

Maetrics announces new president

March 23, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing maetrics, steve cottrell

Maetrics has confirmed that Steve Cottrell, previously its vice president of sales, will now assume the role of president at …
Appointment
Lilly image

Lilly and Hanmi enter immunological therapy pact

March 20, 2015 Research and Development, Sales and Marketing HM71224, Korea, Sjögren, hanmi, immunological, lilly

Eli Lilly and Korean-based pharma firm Hanmi have entered a collaboration agreement to develop and commercialise an immunological therapy. The …
News
michael_r_gallagher_actavis

Actavis gains new Allergan directors

March 20, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Allergan, Michael Gallagher, Peter McDonnell

Ireland, Dublin-based pharma firm Actavis has added former Allergan members Michael Gallagher and Dr Peter McDonnell to its board of …
Appointment
Sanofi image

Type 1 diabetes market value to double by 2023

March 19, 2015 Research and Development, Sales and Marketing GlobalData, NHS, NICE, Sanofi, diabetes, toujeo, type 1

The treatment market for type 1 diabetes is set to double to around $13.6 billion by 2023 according to analysts …
News
Herceptin image

Breast cancer treatment market booming

March 19, 2015 Research and Development, Sales and Marketing Frost, Herceptin, Kadcyla, Roche, breast cancer, oncology, targeted, tykerb

The increased use of combined targeted therapies for breast cancer is set to lift the market and improve progression-free disease …
News
Sanofi image

Sanofi diabetes drug fails to show cardio disease benefit

March 19, 2015 Research and Development, Sales and Marketing ACS, Lixisenatide, Lyxumia, Sanofi, cardio, diabetes

A Phase IIIb study of Sanofi’s diabetes drug lixisenatide has shown it is no better or worse than a placebo …
News
Teva image

Teva and Ignyta shake hands in oncology deal

March 19, 2015 Research and Development, Sales and Marketing CEP-32496, CEP-40125, Levact, RXDX-105, Teva, ignyta, oncology

Ignyta has acquired four oncology R&D assets from Israeli pharma generics giant Teva in a deal worth around $42 million. …
News
paul_wallace

MISSION hires chief business officer from Medivir

March 19, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing medvir, mission, paul wallace

UK, Cambridge-based cancer biotech MISSION Therapeutics has appointed Dr Paul Wallace as its chief business officer. Having worked in business …
Appointment
sharon_johnson_catalent

Catalent Pharma Solutions names new unit head

March 18, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing catalent pharma solutions, sharon johnson

UK pharma and healthcare products firm Catalent Pharma Solutions has picked its senior VP Sharon Johnson of the company’s quality …
Appointment
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026